Avatrombopag T7417
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Avatrombopag is a new oral thrombopoietin (TPO) receptor agonist, activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platelet production.
CAS nr:
570406-98-3
Purity:
98%
Molecular Weight:
649,65
SMILES:
O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1
Formula:
C29H34Cl2N6O3S2
Pathway:
Immunology/Inflammation,Proteases/Proteasome
Target:
Thrombopoietin Receptor,Thrombin
